Despite this strong evidence of early complement factor upregulation in ALS, specific genetic deletion of C1q, C3, and C4 in hSOD1 transgenic mouse models does not confer any beneficial effects on disease progression [9, 10]. This evidence concerns the gene C3 and amyotrophic lateral sclerosis.